Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Taifu Pharmaceutical Co., Ltd., based in Wuhan, Hubei, is a high-tech pharmaceutical company specializing in the research, development, production, and sales of Traditional Chinese Medicine (TCM). Founded in 1965 as Dongshan Pharmaceutical Factory, the company has evolved into a modern enterprise with two production bases and 40 automated production lines. Its product portfolio includes over 60 drug approval numbers across nine dosage forms, including capsules, granules, and tablets. The company's flagship product is the self-developed Sihuang Xiehuo Tablets, which is an exclusive national variety. With annual sales exceeding 200 million RMB, Wuhan Taifu Pharmaceutical serves a nationwide market and is recognized as a High-tech Enterprise in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 武汉太福制药.